Abalone Bio, Inc

Abalone Bio, Inc

Abalone Bio, Inc is a start-up that develops antibody drugs in order to treat diseases.

Abalone Bio, Inc uses libraries of yeast cells to experiment and develop their antibody drugs that fight diseases. The company was founded in Richmond, California, United States.

The company looks to grow specific antibodies that can activate or inhibit a drug target(s). The library can utilize gene sequencing, machine learning, and synthetic biology in order to produce recombinant protein versions of the antibodies and determine their efficacy in human cell assays.

Abalone attempts to find antibodies that can bind GPCRs and ion channels that also do more than blocking signals, but also activate targets or that can turn down target activity. They only work with antibodies that survive the biological enrichment processes they put them through and follow the evolution of antibody populations to find usable samples. Generation DNA sequencing is utilized at this step after a computational algorithm can select a "best hit".

The goal of developing these antibodies drugs is to create options for pain, inflammatory diseases, rare cancer, as well as rare kidney diseases.

Timeline

March 16, 2020
Abalone Bio, Inc raises a $150,000 seed round from Y Combinator.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Abalone Bio, Inc Seed round, March 2020
150,000
March 16, 2020
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Gustavo Pesce

Co-Founder and CSO

Richard Yu

Co-Founder and CEO

Further reading

Title
Author
Link
Type
Date

Abalone Bio - Crunchbase Company Profile & Funding

Web

Home | Abalone Bio

Web

Home | Abalone Bio

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Abalone Bio, Inc

Richmond, California, United States

Antibody drug development

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.